Archive for Category: KD News

Infliximab versus second IVIG for treatment of resistant KD in the USA (KIDCARE)

Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial Summary Background Although intravenous immunoglobulin (IVIG) is effective therapy for Kawasaki disease, 10–20% of patients have recrudescent fever...

Read More

Thank you for your support

To ALL our KD Community who helped raise Kawasaki disease awareness on the 11th National KD Awareness Day, January 26, 2021 – THANK YOU! Together, we helped raise awareness of KD by sharing symptoms and KD facts posts, sharing...

Read More